BIOVIA Discovery Studio
AI in Healthcare
Overview
BIOVIA Discovery Studio by Dassault Systemes is an end-to-end computational drug discovery platform covering target identification through lead optimization. It provides molecular dynamics, free-energy calculations, protein-ligand docking, fragment-based design, de novo drug design, activity profiling, multi-target design, antibody modeling, protein engineering, biologics optimization, QSAR, ADMET, predictive toxicology, and molecular visualization, integrating with the 3DEXPERIENCE platform.
- Pricing model
- Enterprise / custom quote
- Deployment
- SaaS (vendor-hosted), Self-hosted / on-premises
- Regions served
- Global
- Categories
- Vertical application, Workflow orchestration, Biotechnology, Self-hosted / on-premises, Predictive / classical ML, AI in Healthcare, SaaS (vendor-hosted), Enterprise / custom quote
- Last updated
- 2 October 2026
- Published
- 2 October 2026
Use cases
Deployment options
Data sources & provenance
Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.
- Data quality
- Data quality: Editorially Reviewed
- Primary source
- 3ds.com
- Sources cited
- 2
- Last reviewed
- 28 September 2026
- Last updated
- 2 October 2026
Spotted something out of date?
Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.